U.S. testing under way for Abbott's bioresorbable stent

Abbott Laboratories' new Absorb bioresorbable stent has already moved to market in Europe, Asia and South America, and the first U.S. placement of the stent was done last month at North Mississippi Medical Center, one of 200 hospitals collecting data as part of a clinical trial. The Mayo Clinic and Cleveland Clinic are among the hospitals testing the device, and Abbott hopes to seek government approval for U.S. use in 2015.

View Full Article in:

Northeast Mississippi Daily Journal (Tupelo, Miss.) · Press-Enterprise (Riverside, Calif.) (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY